Supplementary Experimental Procedures
siRNA treatment
siRNA against MUS81 (siGENOME SMARTpool D-016143) was purchased from Dharmacon. "Allstars negative control siRNA" was purchased from Qiagen. Cells were transfected with 50nM siRNA using Dharmafect 1 reagent (Dharmacon) and cultured for 48h prior to DNA labelling. Depletion was confirmed by Western Blot using mouse anti-MUS81 (1:500, MTA30 2G10/3, Santa Cruz) and mouse anti-αTubulin (1:5000, Sigma).
siRNA targeting-resistant RAD51 expression constructs
The siRNA targeting-resistant RAD51 expression construct RAD51-Res pcDNA3.1/V5/His-TOPO was generated by site-directed mutagenesis (Quikchange, Stratagene) of RAD51-WT pcDNA3.1/V5/His-TOPO using appropriate oligonucleotides to introduce three silent mutations (underlined):
5'-TGGCTCCAAAGAGCTTGACAAGCTACTGCAGGGTGGAATTGAGACTG-3' and 5'-CAGTCTCAATTCCACCCTGCAGTAGCTTGTCAAGCTCTTTGGAGCCA-
3'

Recombination in SPD8 cells
SPD8 cells were grown in the presence of 5 μg/ml 6-thioguanine to suppress spontaneous recombination. 1.5×10 6 cells were inoculated into 100mm dishes in medium 4 hours prior to a 24-hour treatment with drugs as indicated. Short treatments were made next day. After treatments, the cells were rinsed three times with PBS and 20ml medium added before allowing the cells to recover for 48 h. After recovery, cells were released by trypsinisation and counted. HPRT 
